Form 4 Tracker
CRISPR Therapeutics AG
CRSP

37 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 19, 2026Feb 20 10:36 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
6,967$52.58$366.3K226,106(D)

View →

Feb 19, 2026Feb 20 10:35 PMJames R. KasingerGeneral Counsel and Secretary
Sale
2,112$52.58$111.0K85,115(D)

View →

Apr 3, 2025Jan 27 10:35 PMNaimish PatelChief Medical Officer
Purchase
1,508$32.96$49.7K1,508(D)

View →

Jan 22, 2026Jan 26 10:35 PMRaju PrasadChief Financial Officer
Sale
34,972$60.19$2.1M6,767(D)

View →

Jan 22, 2026Jan 22 10:55 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
60,000$60.23$3.6M134,201(D)

View →

Jan 20, 2026Jan 22 10:55 PMSamarth KulkarniDirector, Chief Executive Officer
Sale
30,000$51.75$1.6M194,201(D)

View →

Jan 22, 2026Jan 22 10:15 PMSamarth Kulkarni
Proposed Sale
60,000$60.81$3.6M—

View →

Jan 22, 2026Jan 22 9:03 PMRAJU PRASAD
Proposed Sale
34,972$60.19$2.1M—

View →

Jan 20, 2026Jan 20 10:11 PMSamarth Kulkarni
Proposed Sale
30,000$52.61$1.6M—

View →

Jan 6, 2026Jan 6 10:11 PMRAJU PRASAD
Proposed Sale
29,700$60.16$1.8M—

View →

Dec 22, 2025Dec 22 9:20 PMRAJU PRASAD
Proposed Sale
10,000$55.95$559.5K—

View →

Feb 18, 2025Feb 18 10:35 PMSamarth Kulkarni
Proposed Sale
45,000$52.22$2.3M—

View →

Nov 11, 2024Nov 12 1:07 PMDr. Samarth Kulkarni
Proposed Sale
75,000$54.86$4.1M—

View →

← Previous

Page 2 of 2

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 14, 2026Oct 16 9:45 PMSimeon GeorgeDirector
Option Exercise
30,000$14.000(D)

View →

Oct 13, 2026Oct 15 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
2,113—0(D)

View →

Oct 13, 2026Oct 15 9:35 PMSamarth KulkarniDirector, Chief Executive Officer
Option Exercise
8,333—0(D)

View →

Oct 6, 2026Oct 8 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
1,990$13.6281,242(D)

View →

Sep 22, 2026Sep 24 9:35 PMJames R. KasingerGeneral Counsel and Secretary
Option Exercise
10,400$13.6283,232(D)

View →

Sep 17, 2026Sep 21 10:40 PMAli BehbahaniDirector
Option Exercise
30,000$14.000(D)

View →

Jun 5, 2026Jun 9 10:09 PMSimeon GeorgeDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 10:06 PMAli BehbahaniDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 9:43 PMMaria FardisDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 9:43 PMHarold Edward FlemingDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 9:43 PMJohn GreeneDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 9:42 PMKatherine A HighDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 9:42 PMSandesh MahatmeDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 9:41 PMBriggs MorrisonDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 9:41 PMChristian RommelDirector
Grant/Award
13,000$51.8413,000(D)

View →

Jun 5, 2026Jun 9 9:40 PMDouglas A TrecoDirector
Grant/Award
13,000$51.8413,000(D)

View →

May 29, 2026Jun 2 9:42 PMJames R. KasingerGeneral Counsel and Secretary
Grant/Award
17,000—17,000(D)

View →

May 29, 2026Jun 2 9:41 PMNaimish PatelChief Medical Officer
Grant/Award
22,000—22,000(D)

View →

May 29, 2026Jun 2 9:41 PMRaju PrasadChief Financial Officer
Grant/Award
19,500—19,500(D)

View →

May 28, 2026Jun 1 9:35 PMNaimish PatelChief Medical Officer
Option Exercise
10,000—20,000(D)

View →

Page 1 of 2

Next →